Cough Suppressant Drugs Market - Snapshot
Three types of medicines can ease a cough caused by a cold or bronchitis: cough suppressants, expectorants, and ointments you apply to your skin called topicals. Suppressants do their job by blocking your cough reflex. Dextromethorphan is the most common ingredient for this. You’ll see it listed as on the bottle or package. This type of medication isn’t used to treat a cough with mucus. And it can’t relieve pain like the medicine codeine -- you'll need a doctor’s prescription for cough suppressant drugs with that in it.
Read Report Overview -
https://www.transparencymarketresearch.com/cough-suppressant-drugs-market.html
This combination medication is used to relieve coughs caused by the common cold, bronchitis, and other breathing illnesses. Guaifenesin belongs to a class of drugs known as expectorants. It works by thinning and loosening mucus in the airways, clearing congestion, and making breathing easier. Dextromethorphan belongs to a class of drugs known as cough suppressants drugs. It acts on a part of the brain (cough center) to reduce the urge to cough.
The doctor may tell you not to treat a cough from a cold unless it keeps you up at night or gets in the way of your daily life. Coughing up mucus helps keep your lungs clear. This is especially true if you smoke or have asthma or emphysema. Dextromethorphan can affect drugs that treat depression. Also, some combination cold and cough medicines contain decongestants, which can raise your blood pressure. So skip them if your BP is high or if you have heart disease.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=68183
Antitussive therapies have gained wide clinical acceptance for treating dry cough and chronic cough, including in cases where the exact cause is hard to identify. These therapies have gained preference in health care due to the fact that they can reduce coughing regardless of the etiology. The drug pipeline in cough-suppressant therapies has grown on the back of the steady demand from the target population in general clinical settings. Drugmakers in the cough suppressants drugs market have tried new mucolytic agents, particularly for managing cough in patients with bronchitis.
Of note, range of products containing these agents have been used for addressing the problem caused due to mucociliary factors. Ongoing efforts to prove the effectiveness of the existing class of protussive agents have created new avenues for pharmaceutical companies in the cough suppressants drugs market. The strides have been stridently bolstered by the adoption of evidence-based guidelines especially that which relate to chronic cough. A growing population seeking outpatient care for chronic bronchitis in hospitals has also spurred the sales of products over the past decades.
Industry efforts to developing drugs that demonstrate consistent action on mucociliary factors have set the tone of innovation in cough suppressants drugs market. In recent years, research on inhaled anticholinergic agents in bronchitis has intensified, which has greatly shaped the product development lifecycle of many drugmakers in the market.
Request for TOC @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=68183
Cough Suppressant Drugs Market Introduction
Cough is a reflex action that clears the throat of mucus or any sort of foreign irritants. Coughing is the most common symptom of a number of medical conditions. According to a study published in the Journal of the Association of Physicians of India, cough is the sixth most common reason for hospital outpatient department visit. Factors that increase the risk of dry cough include exposure to pollutants/environmental irritants, residence close to heavy traffic leading to respiratory problems, cigarette smoking, asthma, chronic obstructive airway disease, use of angiotensin converting enzyme, acute & chronic infections, airway diseases, parenchymal disease, cardiovascular, and gastrointestinal.
Based on type, cough can be divided into acute cough and chronic cough. Cough suppressants are also known as antitussives. Cough suppressants inhibit cough coordinating region in the brain stem. High prevalence of cough is projected to increase demand for cough suppressant drugs during the forecast period, which in turn is anticipated to drive the global cough suppressant drugs market.
Cough Suppressant Drugs Market – Competitive Landscape
The global cough suppressant drugs market is highly fragmented with several domestic players holding key market share in respective region. The low cost of manufacturing, easy availability of these products, large volume business for cough suppressant drugs and easy entry for new players into cough suppressant drugs market. All these factors have attracted large number of domestic manufacturers into this field. Major players operating in the global cough suppressant drugs market focus on business expansion and are engaged in mergers and collaborations.
Request for Analysis of COVID-19 Impact on Cough Suppressant Drugs Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=68183
Perrigo Company plc
Perrigo Company plc is an Ireland-based company that generates 70% of its revenue from the U.S. and has significant presence in the global cough suppressant drugs market. The Company is a leading provider of over-the-counter health and wellness solutions.
Pfizer, Inc
Pfizer, Inc. is another multinational company with strong presence in the cough suppressant drugs market in North America. Pfizer Inc. is a global pharmaceutical company that develops, manufactures, and markets prescription medicines in 11 therapeutic segments, including cardiovascular, oncology, neuroscience, pain, and infectious diseases. It operates through two business units: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH).
GlaxoSmithKline
GlaxoSmithKline is a global pharmaceutical company actively involved in research, development and manufacturing innovative pharmaceutical medicines, vaccines and consumer healthcare products. In 2018, GlaxoSmithKline invested around 4.60 Mn USD for research and development of pipeline products.
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. is a key producer of generic medicines and a recognized leader in innovative and specialty pharmaceuticals worldwide. The company delivers high-quality and patient-centric health care solutions across the globe. It has a wide generic product portfolio with more than 35,000 products in almost every therapeutic area.The company primarily operates through two business segments : Generic medicines and specialty medicines.Teva Pharmaceutical Industries Ltd. markets its gout therapeutic drug under its generic medicines business segment
Other players operating in the global cough suppressant drugs market include Tris Pharma, Inc., Aytu BioScience, Inc., Mayne Pharma Group Limited, and Acella Pharmaceuticals, LLC.
Pre Book Cough Suppressant Drugs Market Report at
https://www.transparencymarketresearch.com/checkout.php?rep_id=68183<ype=S
Cough Suppressant Drugs Market – Dynamics
Anticipated launch and commercialization will drive the cough suppressant drugs market.
A large number of drug candidates are in different stages of clinical trial approval in the U.S. and Europe. The anticipated launch and commercialization of these products is expected to propel the global cough suppressant drugs market during the forecast period.
The cough suppressant drugs market to grow with high prevalence of cough.
According to the Journal of the Association of Physicians of India data, around 54% of population of India suffered from Cough. The global cough suppressant drugs market is projected to expand at a rapid pace during the forecast period. Increase in the geriatric population, changes in lifestyle, and rise in health care awareness are the major factors driving the global market.
Favorable health care policies lead to an increase in affordability of various health care treatments. This, in turn, increases the life expectancy of the population. The population aged above 65 years usually suffers from various health disorders. Hence, increase in the geriatric population augments the global cough suppressant drugs market. However, stringent government regulations for sale of over-the-counter cough suppressant drugs are likely to restrain the global cough suppressant drugs market.
More Trending Reports by Transparency Market Research –
Diagnostic Imaging Services Market:
Cleanroom Consumables Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
